Anastomosis Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Disposable, Reusable), By Application (Cardiovascular Surgery, Gastrointestinal Surgery, Others), By End-use (Hospitals, Ambulatory Care Centers & Clinics), By Region & Competition, 2020-2030F

Market Overview

Global Anastomosis Devices Market was valued at USD 3.60 Billion in 2024 and is anticipated to project steady growth in the forecast period with a CAGR of 5.28% through 2030. The field of medical devices has witnessed significant advancements over the years, and one area that has seen remarkable progress is the development of anastomosis devices. Anastomosis devices play a crucial role in surgical procedures by facilitating the connection of two blood vessels or hollow organs, such as the intestines or ureters, to restore normal blood flow or fluid passage. These devices have become indispensable tools in various surgical specialties, including cardiovascular, gastrointestinal, and urological procedures. The global anastomosis devices market has experienced consistent growth in recent years. This growth can be attributed to several factors, including the increasing prevalence of chronic diseases, an aging population, and advancements in surgical techniques. Anastomosis devices are crucial in surgeries that involve bypass grafting, bowel resections, and organ transplants. As these procedures become more common, the demand for effective anastomosis devices continues to rise.

Surgical staplers are widely used in anastomosis procedures, offering speed and precision. These devices have undergone significant improvements in recent years, with the development of ergonomic designs, better safety features, and minimally invasive options. Traditional suturing techniques remain essential in anastomosis, and there have been innovations in suture materials and delivery methods. Suture-based devices provide surgeons with more options for creating secure and reliable connections. These devices are designed to create a mechanical connection between two tissue segments, eliminating the need for sutures or staples. They are particularly valuable in procedures where precise alignment is crucial. The cardiovascular surgery segment has witnessed significant growth due to the increasing incidence of heart diseases. Vascular anastomosis devices are essential in coronary artery bypass grafting and aortic aneurysm repair.

The global anastomosis devices market is poised for continued growth in the coming years. As surgical techniques become more sophisticated and patient expectations for minimally invasive procedures rise, the demand for innovative anastomosis devices will likely increase. Moreover, the aging global population will drive the need for more complex surgeries, further boosting market growth. The industry can also anticipate increased collaboration between medical device manufacturers, surgeons, and researchers, leading to the development of more advanced and patient-specific solutions. Regulatory bodies will play a critical role in ensuring the safety and efficacy of these devices.

Key Market Drivers

Increasing Surgical Procedures

The growing volume of surgical procedures worldwide is a key factor propelling the expansion of the global anastomosis devices market. Globally, an estimated 220 to 344 million surgical procedures are carried out each year, with high-volume operations such as cataract removal, cesarean deliveries, and orthopedic joint replacements accounting for a substantial share. Despite this high procedural volume, disparities in access to safe, timely, and cost-effective surgical care persist particularly in low- and middle-income countries posing a critical barrier to healthcare equity and infrastructure development. Anastomosis devices are crucial in connecting blood vessels, gastrointestinal tracts, or other tubular structures during surgery. As the demand for surgical interventions rises, so does the need for reliable, efficient, and minimally invasive anastomosis solutions.  Each year, an estimated 2 million patients worldwide undergo open-heart surgery, primarily to address coronary artery disease, valvular dysfunction, and congenital heart defects. These complex procedures often require precise vascular reconnections, making them heavily reliant on high-performance anastomosis devices. The global burden of chronic diseases such as cardiovascular disorders, cancer, gastrointestinal diseases, and obesity is increasing significantly. These conditions often require surgical interventions, including coronary artery bypass grafting (CABG), colorectal surgeries, and bariatric procedures, all of which involve some form of anastomosis. With more patients undergoing these procedures, hospitals and surgical centers are placing greater emphasis on adopting advanced anastomosis devices that reduce surgery time, lower complication rates, and improve patient outcomes. This creates a consistent and growing demand for such devices.

The medical field is witnessing a strong shift towards minimally invasive surgeries (MIS) and robot-assisted procedures, driven by the benefits of reduced recovery time, less post-operative pain, and lower infection risk. These techniques often rely on sophisticated anastomosis devices to ensure precise, secure connections in confined surgical fields. As hospitals and healthcare providers increasingly adopt MIS and robotic techniques, the market for specialized and compatible anastomosis devices expands proportionally. The global population is aging, with a substantial increase in the number of elderly individuals prone to conditions requiring surgical intervention. Older patients often undergo gastrointestinal, cardiovascular, or thoracic surgeries, which necessitate effective anastomosis. This demographic trend directly contributes to market growth, as anastomosis devices are indispensable in procedures tailored to senior patients, who require more reliable and less traumatic surgical solutions. Developing regions such as Asia-Pacific, Latin America, and the Middle East are witnessing a rise in surgical volumes due to improvements in healthcare infrastructure, increased access to surgical care, and growing government healthcare expenditures. This infrastructure development supports the adoption of modern surgical tools, including anastomosis devices, especially in urban hospitals and specialty centers, thus expanding the global market footprint.

Increasing Prevalence of Chronic Diseases

The global rise in chronic diseases is a fundamental driver fueling the demand for anastomosis devices, significantly shaping the trajectory of the global anastomosis devices market. As chronic illnesses increasingly impact the global population, the need for surgical intervention continues to grow—thereby reinforcing the critical role of anastomosis devices in modern healthcare delivery. Annually, cardiovascular diseases including conditions that lead to heart attacks, strokes, and heart failure account for approximately 18 million deaths, making them the leading cause of mortality worldwide. In parallel, cancers contribute to around 9 million deaths, while chronic respiratory illnesses such as asthma and COPD claim another 4 million lives. Diabetes-related complications result in an additional 2 million deaths each year. A significant portion of chronic conditions—such as cardiovascular disease, cancer, diabetes, gastrointestinal disorders, and obesity—frequently progress to a stage where surgical intervention becomes necessary. These surgeries often involve the resection or reconnection of organs, tissues, or vessels, where anastomosis plays a central role. Colorectal cancer or inflammatory bowel disease (IBD) often involve bowel resection surgeries requiring precise anastomotic techniques. In 2023, an estimated 153,020 new cases of colorectal cancer (CRC) will be diagnosed, with 52,550 related deaths projected—including 19,550 diagnoses and 3,750 fatalities among individuals under the age of 50. As the prevalence of such diseases rises, so does the demand for advanced and reliable anastomosis solutions.

Chronic disease patients are typically at higher risk for surgical complications, including infections, delayed healing, and anastomotic leaks. To mitigate these risks, hospitals and surgeons are increasingly adopting specialized anastomosis devices that improve procedural accuracy, reduce operative time, and enhance post-surgical outcomes. This shift toward high-performance and safety-oriented devices is driving innovation and uptake in the anastomosis devices market, especially in tertiary care hospitals and surgical centers. In 2021, noncommunicable diseases (NCDs) were responsible for over 43 million deaths, accounting for 75% of all non-pandemic-related mortality worldwide. 18 million of these deaths occurred in individuals under the age of 70, with 82% of premature fatalities concentrated in low- and middle-income countries, and this number is projected to rise. With aging populations and lifestyle shifts contributing to the global disease burden, healthcare systems are experiencing increased surgical case volumes, many of which involve anastomotic procedures. This steady increase in surgical cases creates a robust and expanding end-user base for anastomosis devices, including hospitals, clinics, and ambulatory surgical centers.

Increasing Disposable Income

In recent years, the global healthcare industry has witnessed significant growth, driven by a combination of factors including advances in medical technology, increasing healthcare awareness, and rising disposable incomes. One particular segment of the healthcare market that has been experiencing substantial growth is the Anastomosis Devices Market. Anastomosis devices play a crucial role in various surgical procedures, and the demand for these devices has been on the rise, primarily due to the increasing disposable income of individuals worldwide.

Anastomosis procedures can be costly, and individuals with higher disposable incomes are more likely to opt for such surgeries when needed. As disposable income rises, more people can afford these surgical treatments, thereby increasing the demand for Anastomosis devices. Higher disposable incomes often translate into better access to advanced healthcare facilities. Patients with more financial resources can choose hospitals and healthcare providers that offer the latest surgical techniques and technologies, including Anastomosis devices. Individuals with substantial disposable income may be willing to travel to different countries for medical treatments. This has led to a global market for healthcare services, including Anastomosis procedures, benefiting device manufacturers.

Download Free Sample Report

Key Market Challenges

Regulatory Hurdles

One of the significant challenges faced by the Anastomosis Devices market is the stringent regulatory approval process. Regulatory bodies, such as the Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) in Europe, have strict guidelines and requirements for medical devices' safety and efficacy. Meeting these regulatory requirements can be time-consuming and costly for manufacturers, leading to delays in product launches and increased expenses.

Lack of Skilled Surgeons

Anastomosis procedures require a high level of surgical skill and precision. However, there is a shortage of skilled surgeons in many regions, especially in developing countries. The lack of trained professionals can limit the adoption of Anastomosis Devices, as healthcare facilities may be reluctant to invest in advanced devices without qualified personnel to operate them effectively.

High Cost of Anastomosis Devices

Advanced Anastomosis Devices, such as surgical staplers and suturing devices, come with a hefty price tag. The high cost of these devices can be a significant barrier for healthcare facilities, particularly in resource-limited settings. As a result, some hospitals and clinics may opt for traditional, lower-cost methods of anastomosis, hindering market growth.

Key Market Trends

Technological Advancements

In the ever-evolving landscape of healthcare, technological advancements play a pivotal role in enhancing patient outcomes and improving surgical procedures. One such field that has witnessed remarkable progress is the global Anastomosis Devices market. Anastomosis, the surgical connection of two structures, has seen a significant transformation due to innovative technological developments. These advancements have not only simplified surgical procedures but also paved the way for better patient recovery and outcomes.

The most significant technological advancements in the Anastomosis Devices market is the adoption of minimally invasive surgical techniques. Devices like robotic surgical systems and laparoscopic instruments have made complex anastomosis procedures more precise, less invasive, and have reduced patients' recovery times. High-resolution imaging technologies like 3D imaging, augmented reality, and intraoperative imaging systems have empowered surgeons with better visualization during procedures. This not only aids in more accurate anastomosis but also allows for real-time adjustments, ensuring the best possible outcomes. The use of advanced biomaterials and tissue engineering techniques has revolutionized anastomosis. These materials promote tissue regeneration and healing, reducing the risk of complications. Bio-absorbable staples and tissue adhesives are prime examples of such innovations. Surgical staplers have evolved significantly. Modern stapling devices come with adjustable staple heights, tissue thickness sensing, and real-time feedback systems, ensuring that each staple is placed accurately and securely. Electrosurgical instruments have gained popularity due to their precision and efficiency in creating anastomosis. These devices use electrical energy to cut and coagulate tissues, reducing bleeding and postoperative complications. Technological advancements have also expanded the reach of surgical expertise through telemedicine and remote assistance. Surgeons can now collaborate with colleagues worldwide, providing insights and guidance during complex anastomosis procedures.

The global Anastomosis Devices market is experiencing rapid growth, driven by these technological advancements. As healthcare providers and patients alike demand safer, less invasive, and more effective surgical solutions, the market is expected to continue its upward trajectory. In addition to improving patient outcomes, these advancements also have economic implications by reducing hospital stays and postoperative care costs. Furthermore, ongoing research and development in materials science, robotics, and artificial intelligence promise even more innovations in the field. These developments may lead to further refinement of anastomosis techniques, making surgery even less invasive and more precise.

Segmental Insights

Product Insights

Based on the Product, the disposable segment emerged as the fastest growing segment in the global market for Anastomosis Devices in 2024. The primary advantages of disposable anastomosis devices is their role in infection control. These devices are used once and then discarded, reducing the risk of cross-contamination and healthcare-associated infections. Healthcare facilities prioritize patient safety, making disposable devices a preferred choice. While disposable devices have an upfront cost, they can be more cost-effective in the long run for healthcare providers. Reusable devices require sterilization, maintenance, and potential repairs, which can be expensive and time-consuming. Disposable devices are ready for immediate use and do not require sterilization, which can save valuable time in surgical procedures. Surgeons and medical staff can focus on patient care rather than device maintenance. Using disposable devices can reduce a healthcare facility's liability. In case of any adverse events or infections associated with reusable devices, the facility may face legal and financial consequences. Disposable devices can mitigate these risks. Over the years, disposable anastomosis devices have seen significant technological advancements, making them more efficient and user-friendly. This has contributed to their growing popularity among healthcare professionals. Disposable devices often comply with strict regulatory standards and quality control measures. Ensuring compliance with these regulations is easier with single-use devices, which can be a crucial factor in the healthcare industry. Disposable devices support the practice of preventive medicine by reducing the risk of complications and infections associated with surgical procedures. This aligns with the healthcare industry's focus on patient outcomes and safety.

Application Insights

The cardiovascular surgery segment is projected to experience rapid growth during the forecast period. Cardiovascular diseases, such as coronary artery disease and peripheral artery disease, are among the leading causes of death worldwide. These conditions often require surgical interventions, including coronary artery bypass grafting (CABG) and vascular surgeries, which involve creating connections (anastomoses) between blood vessels. The prevalence of cardiovascular diseases drives the demand for anastomosis devices. The global population is aging, leading to an increase in the number of people with cardiovascular issues. Older individuals are more likely to require surgical treatments, contributing to the growth of the cardiovascular surgery segment within the anastomosis devices market.

Download Free Sample Report

Regional Insights

North America emerged as the largest market in the global Anastomosis Devices market in 2024, holding the largest market share in terms of value. North America, particularly the United States and Canada, boasts some of the most advanced healthcare infrastructures globally. This includes well-equipped hospitals, research facilities, and a highly skilled healthcare workforce. This infrastructure allows for the widespread adoption of medical devices like anastomosis devices. North America has a high healthcare expenditure per capita, which means that there is more financial capacity to invest in advanced medical technologies, including anastomosis devices. Insurance coverage and reimbursement policies in the region also play a significant role in encouraging the use of such devices. An aging population often requires more medical interventions, including surgeries that may involve the use of anastomosis devices. North America has an aging demographic, which can drive demand for these devices.

Recent Developments

• In May 2024, Ethicon, a Johnson & Johnson MedTech company, has officially launched the ECHELON LINEAR™ Cutter in the U.S. market—marking a significant advancement in surgical stapling technology. As the first linear cutter to integrate both 3D-Stapling Technology and Gripping Surface Technology (GST), the device brings together two proprietary innovations designed to enhance staple line integrity and reduce intraoperative risk. Clinical data shows the ECHELON LINEAR™ Cutter delivered a 47% reduction in staple line leaks, a critical metric in minimizing post-operative complications and improving patient outcomes.
• In March 2024, Getinge has received FDA 510(k) clearance for the Vasoview Hemopro 3, the newest addition to its portfolio of endoscopic vessel harvesting (EVH) solutions. Engineered with direct input from clinical users, the Hemopro 3 is designed to enhance procedural efficiency and workflow precision in cardiovascular surgeries.
• In March 2024, Advanced Medical Solutions Group plc announced a definitive agreement to acquire Peters Surgical, a prominent international provider of specialty surgical sutures, mechanical haemostasis solutions, and internal cyanoacrylate-based devices. This strategic acquisition is set to significantly expand AMS’s surgical portfolio, enhance its global footprint, and strengthen its position in high-growth, high-margin segments of the surgical market.

Key Market Players

• Medtronic plc
• LivaNova PLC
• MAQUET Holding B.V. & Co. KG.
• Dextera Surgical Inc.
• Vitalitec Internaional Inc.
• Synovis Micro Companies Alliance, Inc.
• Ethicon US, LLC
• Peters Surgical SASU

Report Scope:

In this report, the Global Anastomosis Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Anastomosis Devices Market, By Product:

o   Disposable

o   Reusable

• Anastomosis Devices Market, By Application:

o   Cardiovascular Surgery

o   Gastrointestinal Surgery

o   Others

• Anastomosis Devices Market, By End-Use:

o   Hospitals

o   Ambulatory Care Centres & Clinics

• Anastomosis Devices Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia-Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Anastomosis Devices Market.

Available Customizations:

Global Anastomosis Devices market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Anastomosis Devices Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com